Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Michael DiStefano

Concepts (55)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Negotiating
3
2024
26
2.680
Why?
Medicare
4
2024
666
2.050
Why?
Medicare Part D
3
2023
25
1.760
Why?
Prescription Drugs
2
2023
116
1.430
Why?
Alzheimer Disease
2
2022
438
1.130
Why?
Direct-to-Consumer Advertising
1
2023
4
0.880
Why?
Cost-Benefit Analysis
3
2024
548
0.840
Why?
Medicare Part C
1
2023
25
0.840
Why?
Health Equity
1
2023
57
0.820
Why?
Drug Industry
1
2023
104
0.790
Why?
Public Opinion
1
2022
59
0.780
Why?
Pharmaceutical Preparations
1
2023
169
0.740
Why?
United States
11
2024
12322
0.550
Why?
Fellowships and Scholarships
1
2019
241
0.530
Why?
Emergency Medicine
1
2019
239
0.520
Why?
Education, Medical, Graduate
1
2019
378
0.500
Why?
Drug Costs
3
2023
91
0.430
Why?
Curriculum
1
2019
856
0.430
Why?
Quality Improvement
1
2019
958
0.390
Why?
Pediatrics
1
2019
986
0.380
Why?
Economics, Pharmaceutical
2
2019
10
0.350
Why?
Aged
7
2024
19296
0.340
Why?
Costs and Cost Analysis
2
2023
200
0.260
Why?
Humans
13
2024
115879
0.230
Why?
Hemophilia B
1
2023
36
0.230
Why?
Quality-Adjusted Life Years
1
2024
103
0.220
Why?
Medicare Part B
1
2023
6
0.220
Why?
Technology Assessment, Biomedical
1
2023
29
0.220
Why?
National Health Programs
1
2023
20
0.220
Why?
Hemophilia A
1
2023
70
0.210
Why?
South Africa
1
2023
162
0.210
Why?
Mental Competency
1
2022
25
0.200
Why?
Health Expenditures
1
2023
173
0.200
Why?
Drug Approval
1
2022
78
0.190
Why?
United States Food and Drug Administration
1
2022
173
0.190
Why?
Informed Consent
1
2022
163
0.190
Why?
Policy
1
2022
140
0.180
Why?
Patient Participation
1
2024
362
0.180
Why?
Economic Competition
1
2019
13
0.170
Why?
Legislation, Drug
1
2019
73
0.160
Why?
Research Design
1
2024
949
0.150
Why?
Antibodies, Monoclonal, Humanized
1
2022
666
0.150
Why?
Program Development
1
2019
350
0.140
Why?
Cohort Studies
1
2023
4960
0.110
Why?
Cross-Sectional Studies
1
2023
4447
0.100
Why?
Surveys and Questionnaires
1
2022
4675
0.090
Why?
Retrospective Studies
2
2023
12616
0.090
Why?
Colorado
1
2019
4122
0.080
Why?
Genetic Therapy
1
2023
267
0.050
Why?
Medicaid
1
2023
411
0.040
Why?
Japan
1
2019
89
0.040
Why?
Ontario
1
2019
108
0.040
Why?
Public Policy
1
2019
61
0.040
Why?
Male
1
2023
56117
0.040
Why?
Female
1
2023
60082
0.040
Why?
DiStefano's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)